Contrast-enhanced MRI index of diffuse myocardial fibrosis is increased in primary aldosteronism

Journal of Magnetic Resonance Imaging

Volumn 35, Issue 6, 2012, Pages 1349-1355

  Su, Mao Yuan M ^a   Wu, Vin Cent ^a,b   Yu, Hsi Yu ^a   Lin, Yen Hung ^a,b   Kuo, Chin Chi ^a,b   Liu, Kao Lang ^a   Wang, Shuo Meng ^a   Chueh, Shih Chieh ^a   Lin, Lian Yu ^a,b   Wu, Kwan Dun ^a,b   Tseng, Wen Yih I ^a,c  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPAI   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

chamber stiffness; diffuse myocardial fibrosis; fibrosis index; late gadolinium enhancement MRI; primary aldosteronism

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL ARTICLE; CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIFFUSE MYOCARDIAL FIBROSIS; FEMALE; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE FILLING; HEART MUSCLE FIBROSIS; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; IMAGE ENHANCEMENT; INFECTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL; VALVULAR HEART DISEASE;

ALGORITHMS; CONTRAST MEDIA; ENDOMYOCARDIAL FIBROSIS; FEMALE; GADOLINIUM DTPA; HUMANS; HYPERALDOSTERONISM; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84862063466     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.23592     Document Type: Article

References (38)

1. Conn JW,. Primary aldosteronism. J Lab Clin Med 1955; 45: 661-664.
2. Gaddam KK, Pimenta E, Husain S, Calhoun DA,. Aldosterone and cardiovascular disease. Curr Probl Cardiol 2009; 34: 51-84.
3. Brilla CG, Weber KT,. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 1992; 26: 671-677.
4. Brilla CG, Weber KT,. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J Lab Clin Med 1992; 120: 893-901. (Pubitemid 23002899)
5. Sun Y, Ramires FJ, Weber KT,. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc Res 1997; 35: 138-147. (Pubitemid 27374751)
6. Gavras H, Kremer D, Brown JJ, et al. Angiotensin- and norepinephrine-induced myocardial lesions: experimental and clinical studies in rabbits and man. Am Heart J 1975; 89: 321-332.
7. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT,. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 1989; 64: 1041-1050. (Pubitemid 19155774)
8. Rossi GP, Rossi GP, Di Bello V, et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism. Hypertension 2002; 40: 23-27. (Pubitemid 34755974)
9. Ohno M, Cheng CP, Little WC,. Mechanism of altered patterns of left ventricular filling during the development of congestive heart failure. Circulation 1994; 89: 2241-2250. (Pubitemid 24142804)
10. Tseng WY, Liao TY, Wang JL,. Normal systolic and diastolic functions of the left ventricle and left atrium by cine magnetic resonance imaging. J Cardiovasc Magn Reson 2002; 4: 443-457.
11. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ,. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005; 26: 1461-1474. (Pubitemid 41373486)
12. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002; 106: 2322-2327. (Pubitemid 35244732)
13. Kim RJ, Choi KM, Judd RM,. Assessment of myocardial viability by contrast enhancement. In:, Higgins CB, de Roos A, editors. Cardiovascular MRI and MRA. Philadelphia, PA: Lippincott Williams and Wilkins; 2003. p 209-237.
14. Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99m Tc-DTPA autoradiography in rats. Radiology 1999; 211: 698-708. (Pubitemid 29249466)
15. Jerosch-Herold M, Sheridan DC, Kushner JD, et al. Cardiac magnetic resonance imaging of myocardial contrast uptake and blood flow in patients affected with idiopathic or familial dilated cardiomyopathy. Am J Physiol Heart Circ Physiol 2008; 295: H1234-H1242.
16. Iles L, Pfluger H, Phrommintikul A, et al. Evaluation of diffuse myocardial fibrosis in heart failure with cardiac magnetic resonance contrast-enhanced T1 mapping. J Am Coll Cardiol 2008; 52: 1574-1480.
17. Broberg CS, Chugh SS, Conklin C, Sahn DJ, Jerosch-Herold M,. Quantification of diffuse myocardial fibrosis and its association with myocardial dysfunction in congenital heart disease. Circ Cardiovasc Imaging 2010; 3: 727-734.
18. Flett AS, Hayward MP, Ashworth MT, et al. Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: preliminary validation in humans. Circulation 2011; 122: 138-144.
19. Kuo CC, Hsu HL, Huang CY, et al.; Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). A patient with concurrent primary aldosteronism and Page kidney. Endocrine 2010; 38: 6-10.
20. Kellman P, Arai AE, McVeigh ER, Aletras AH,. Phase-sensitive inversion recovery for detecting myocardial infarction using gadolinium-delayed hyperenhancement. Magn Reson Med 2002; 47: 372-83. (Pubitemid 34116807)
21. Appleton CP,. Doppler assessment of left ventricular diastolic function: the refinements continue. J Am Coll Cardiol 1993; 21: 1697-1700. (Pubitemid 23170447)
22. De Roos A, Van Rossum AC, van der Wall EE, et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA-enhanced MR imaging. Radiology 1989; 172: 717-720. (Pubitemid 19211591)
23. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA,. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI: potential mechanisms. Circulation 1995; 92: 1117-1125.
24. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM,. Contrast-enhanced magnetic resonance imaging of myocardium atrisk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36: 1985-1991.
25. Kim RJ, Fieno DS, Parrish TB, et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation. 1999; 100: 1992-2002. (Pubitemid 29529292)
26. Rehwald WG, Fieno DS, Chen EL, Kim RJ, Judd RM,. Myocardial magnetic resonance imaging contrast agent concentrations after reversible and irreversible ischemic injury. Circulation 2002; 105: 224-249.
27. Weber KT, Sun Y, Campbell SE,. Structural remodelling of the heart by fibrous tissue: role of circulating hormones and locally produced peptides. Eur Heart J 1995; 16: 12-18. (Pubitemid 26082316)
28. Robert V, Van Thiem N, Cheav SL, Mouas C, Swynghedauw B, Delcayre C,. Increased cardiac types I and III collagen mRNAs in aldosterone-salt hypertension. Hypertension 1994; 24: 30-36. (Pubitemid 24195401)
29. Sanderson JE, Cockram CS, Yu CM, Campbell SE, Weber KT,. Myocardial fibrosis and hyperaldosteronism. Eur Heart J 1996; 17: 1761-1762.
30. Messroghli DR, Radjenovic A, Kozerke S, Higgins DM, Sivananthan MU, Ridgway JP,. Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med 2004; 52: 141-146. (Pubitemid 39295266)
31. Mewton N, Liu CY, Croisille P, Bluemke D, Lima JA,. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011; 57: 891-903.
32. Hirota Y,. A clinical study of left ventricular relaxation. Circulation 1980; 62: 756-763. (Pubitemid 10009691)
33. Dougherty AH, Naccarelli GV, Gray EL, Hicks C, Goldstein RA,. Congestive heart failure with normal systolic function. Am J Cardiol 1984; 54: 778-782. (Pubitemid 14006147)
34. Soufer R, Wohlgelernter D, Vita NA, et al. Intact systolic left ventricular function in clinical congestive heart failure. Am J Cardiol 1984; 53: 567-571.
35. Thomas JD, Weyman AE,. Echocardiographic Doppler evaluation of left ventricular diastolic function. Physics and physiology. Circulation 1991; 84: 977-990.
36. Little WC, Ohno M, Kitzman DW, Thomas JD, Cheng CP,. Determination of left ventricular chamber stiffness from the time for deceleration of early left ventricular filling. Circulation 1995; 92: 1933-1939.
37. Kitzman DW, Edwards WD,. Age-related changes in the anatomy of the normal human heart. J Gerontol 1990; 45: M33-39. (Pubitemid 20104829)
38. Krishnamurthy R, Pednekar A, Cheong B, Muthupillai R,. High temporal resolution SSFP cine MRI for estimation of left ventricular diastolic parameters. J Magn Reson Imaging 2010; 31: 872-880.